Fan, Ya-Ping, Rajinder N. Puri, and Satish Rattan. Animal model for angiotensin II effects in the internal anal sphincter smooth muscle: mechanism of action. Am J Physiol Gastrointest Liver Physiol 282: G461-G469, 2002; 10.1152/ ajpgi.00207.2001 , but a number of neurohumoral factors may exert modulatory effects on the tone. However, the knowledge of neurohumoral factors causing a rise in the basal tone of the IAS is very limited. ANG II is a potent smooth muscle contractile neurohumoral agonist (9, 28). Three main types of ANG II receptors have been described AT 1 , AT 2 , and AT 4 . A majority of ANG II actions is known to be mediated by the specific activation of AT 1 . AT 1 receptor is a member of a superfamily of peptide hormone receptors with seven membrane-spanning regions linked to G proteins. Most of the actions of AT 1 receptor are mediated via the activation of phospholipase C that hydrolyzes phosphatidyl inositol 4,5-bisphosphate to produce inositol 1,4, 5-trisphosphate (IP 3 ) and diacylglycerol. IP 3 and diacylglycerol in turn lead to increase in the levels of free intracellular Ca 2ϩ concentration and activation of protein kinase C (PKC), respectively. In addition, AT 1 receptor activation may lead to influx of Ca 2ϩ and activation of tyrosine kinase pathway (9, 26, 27, 29) . AT 2 receptors on the other hand have been suggested to attenuate the responses mediated by the AT 1 receptors (8), in different systems. Besides its direct action on the smooth muscle, ANG II may cause smooth muscle contraction by indirect effects by the release of autacoids such as prostaglandins and histamines, activation of sympathetic nerve terminals, nitric oxide synthase pathway, and via the release of endothelins and growth factors (9, 13, 28) .
INTERNAL ANAL SPHINCTER (IAS) smooth muscle tone plays a pivotal role in anorectal continence. IAS smooth muscle tone is primarily myogenic in nature (3, 24) , but a number of neurohumoral factors may exert modulatory effects on the tone. However, the knowledge of neurohumoral factors causing a rise in the basal tone of the IAS is very limited.
ANG II is a potent smooth muscle contractile neurohumoral agonist (9, 28) . Three main types of ANG II receptors have been described AT 1 , AT 2 , and AT 4 . A majority of ANG II actions is known to be mediated by the specific activation of AT 1 . AT 1 receptor is a member of a superfamily of peptide hormone receptors with seven membrane-spanning regions linked to G proteins. Most of the actions of AT 1 receptor are mediated via the activation of phospholipase C that hydrolyzes phosphatidyl inositol 4,5-bisphosphate to produce inositol 1,4, 5-trisphosphate (IP 3 ) and diacylglycerol. IP 3 and diacylglycerol in turn lead to increase in the levels of free intracellular Ca 2ϩ concentration and activation of protein kinase C (PKC), respectively. In addition, AT 1 receptor activation may lead to influx of Ca 2ϩ and activation of tyrosine kinase pathway (9, 26, 27, 29) . AT 2 receptors on the other hand have been suggested to attenuate the responses mediated by the AT 1 receptors (8) , in different systems. Besides its direct action on the smooth muscle, ANG II may cause smooth muscle contraction by indirect effects by the release of autacoids such as prostaglandins and histamines, activation of sympathetic nerve terminals, nitric oxide synthase pathway, and via the release of endothelins and growth factors (9, 13, 28) .
Despite the abundant literature in different smooth muscles, there are limited data on the effects of ANG II in the gastrointestinal smooth muscle that characterizes the mechanism and site(s) of excitatory effect, type of ANG II receptors, and receptor distribution (1, 9) . As it relates to the tonic smooth muscle of the gastrointestinal tract, studies (19) have been reported primarily in the lower esophageal sphincter (LES). Those studies were primarily limited to the ANG II effects (19) rather than specific information on ANG II receptors and signal transduction mechanisms. Effects and mechanism of action of ANG II in the IAS have not been reported before.
Because ANG II has been shown to exert potent contractile effects in different smooth muscles, it was considered important to investigate ANG II actions in the IAS. The IAS smooth muscle tone, like that in the LES, is primarily myogenic in nature but can be modulated by the neurohumoral factors (3, (10) (11) (12) . The IAS has significant importance in the pathophysiology of a number of motility disorders such as anorectal incontinence and severe constipation (15, 23) . Anorectal incontinent patients could benefit from agents that cause selective increase in the IAS tone. The studies were therefore designed to compare the effects of ANG II in the IAS of different species and then to pursue, in depth, the site and mechanism of action of ANG II and relative distribution of AT 1 versus AT 2 receptors in the species that showed pronounced and reproducible effects.
MATERIALS AND METHODS
Preparation of smooth muscle strips. Adult Sprague-Dawley rats (weighing ϳ250 g) of either sex were used for the study. Some studies were also carried out in opossums (Didelphis virginiana) (weighing from 2 to 3.5 kg) and New Zealand rabbits (weighing from 2.5 to 3.5 kg). All experimental procedures in animals were carried out in accordance with the approved standards described in the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health, 1985 . Animals were anaesthetized with pentobarbital sodium (50 mg/kg ip) followed by laparotomy. Studies focused primarily on the IAS, the lower-most smooth muscle of the gastrointestinal tract. Some studies were also carried out in the smooth muscles of the distal colon adjacent to the IAS (rectum), the LES, and the adjacent esophageal body. The isolated organs were transferred immediately to oxygenated (95% O 2-5% CO2) Krebs solution of the following composition (in mM): 118.07 NaCl, 4.69 KCl, 2.52 CaCl 2, 1.16 MgSO4, 1.01 NaH2PO4, 25 NaHCO 3, and 11.10 glucose. The respective smooth muscle tissues were carefully freed of the adjoining nonsmooth muscle tissues and other extraneous structures, opened, and pinned flat with the mucosal side up on a dissecting tray containing oxygenated Krebs solution. Mucosal and submucosal layers were removed by sharp dissection, and circular smooth muscle strips (ϳ1 ϫ 10 mm) of esophageal body, LES, IAS, and rectal circular smooth muscle were prepared for the recording of isometric tension as described previously (5) .
Measurement of isometric tension. Different smooth muscle strips prepared above were secured at both ends with silk sutures and transferred to 2-ml muscle baths containing oxygenated Krebs solution at 37°C. One end of the muscle strip was anchored at the bottom of the muscle bath and the other attached to the force transducer (model FT03; Grass Instruments, Quincy, MA). Isometric tension was measured using computerized PowerLab recorder (CB Sciences, Milford, MA). The muscle strips were initially stretched with 10 mN of force and then allowed to equilibrate for at least 1 h with regular washing at 20-min intervals. Only the strips that developed a spontaneous and steady tone and relaxed in response to electrical field stimulation were considered for the studies on the IAS and LES. Optimal length of each smooth muscle was determined in the beginning of the experiment, and baseline to measure the active tone of the smooth muscle strips was determined at the end of each experiment, as described previously (5, 18) .
Effects of different concentrations of agonists on the isometric tension of each smooth muscle strip were examined in a cumulative manner before and after the addition of different antagonists. Each smooth muscle served as its own control. The antagonists were added 15 min before repeating the concentration-response curve. Concentrations of different antagonists used have been previously determined to be selective in blocking their respective actions or pathways. At the conclusion of each experiment, the smooth muscle strips were carefully freed from the suture material, blotted dry, and weighed accurately. Isometric tension was expressed either on absolute basis in gram or as millinewtons, and smooth muscle contractions were expressed as percent maximal contraction obtained with 1 ϫ 10 Ϫ4 M bethanechol (5).
Isolation of the smooth muscle cells. IAS smooth muscle cells (SMCs) were isolated as described before (6) . Briefly, the smooth muscle tissues were cut into small pieces (1-mm cubes) and incubated in oxygenated Krebs solution containing 0.1% collagenase (CLS II, 217 U/mg dry weight), 0.01% soybean trypsin inhibitor, and mixtures of amino acids and multivitamins at 31°C for two successive 60-min periods. Partially digested tissue pieces were then filtered through a 500-m Nitex mesh. The tissues trapped on the mesh were rinsed with 5-ml collagenase-free Krebs solution and incubated for another 30 min in oxygenated Krebs solution to disperse the SMCs. The SMCs were harvested by filtration through a 500-m Nitex mesh, centrifuged at 350 g for 10 min, and resuspended to obtain about 3,000 to 4,000 cells/mm 3 . Measurement of changes in SMC lengths by scanning micrometry. Lengths of the isolated SMC were measured by scanning micrometry as described previously (6) . Aliquots (30 l) of the rat IAS-SMC were treated either with bethanechol (1 ϫ 10 Ϫ4 M) or ANG II (1 ϫ 10 Ϫ7 M) for 5 min followed by their fixation with 0.1% acrolein. The mean length of 30 SMC at random was determined by micrometry using phase contrast microscopy, and the results were calculated as percentage of control cell length or shortening. To examine the effects of the specific antagonists on the ANG II-induced contraction of SMC, the inhibitors were added 15 min before the addition of different concentrations of ANG II.
Western blot analyses. Western blot analyses to determine the relative distribution of AT1 and AT2 receptors were performed following the approach previously described in our laboratory (5) . Respective tissues were cut into small pieces, rapidly homogenized in five volumes of boiling lysis buffer (1% SDS, 1.0 mM sodium orthovanadate, and 10 mM Tris, pH 7.4), and then microwaved for 10 s. The homogenates were centrifuged (16,000 g, 4°C) for 15 min, and the protein contents in resultant supernatants were determined by the method of Lowry et al. (17) using BSA as the standard. All of the samples were mixed with 2ϫ sample buffer (125 mM Tris pH6.8, 4% SDS, 10% glycerol, 0.006% bromophenol blue, and 2% ␤-mercaptoethanol) and placed in a boiling water bath for 3 min. An aliquot (of 20 l containing 40 g protein) of each sample was separated by 7.5% SDS-polyacrylamide gel. The separated proteins were electrophoretically transferred onto a nitrocellulose membrane at 4°C. To block nonspecific antibody binding, the nitrocellulose membrane was soaked overnight at 4°C in Tris-buffered saline Tween (TBS-T; composed of: 20 mM Tris pH 7.6, 137 mM NaCl, and 0.1% Tween-20) containing 1% BSA. The nitrocellulose membranes were then incubated with the specific primary antibodies (1:1,000 for AT1) or anti-sera to AT2 receptor (raised in rabbit, 1:2,000), for 1 h at room temperature. After washing with TBS-T, the membranes were incubated with the horseradish peroxidase labeled-secondary antibody (donkey anti-rabbit IgG, 1:1,500 dilution) for 1 h at room temperature. The corresponding bands were visualized with enhanced chemiluminescence substrate using a Western blot detection kit and Hyperfilm MP (Amersham Life Science). Bands corresponding to different proteins on X-ray films were scanned (SnapScan.310; Agfa, Ridgefield Park, NJ) and their relative densities determined by using Image-Pro Plus 4.0 software (Media Cybernetics; Silver Spring, MD).
Drugs and chemicals. The following chemicals were used in the study: ANG II, H-7, tyrphostin B46, and Rho kinase inhibitor HA-1077 (20) 
RESULTS

Effect of ANG II on rat basal tone of IAS smooth muscle.
ANG II caused a concentration-dependent rise in the basal tone of rat IAS (Fig. 1) . Maximal increase in rat IAS tone of 39.3 Ϯ 0.5% was observed with 1 ϫ 10 Ϫ7 M. The threshold concentration of ANG II was 1 ϫ 10 Ϫ10 M that caused an increase in the basal IAS tone of 5.9 Ϯ 0.6%. A typical tracing to exemplify the effect of ANG II in the rat versus the rabbit and opossum IAS has been shown in Fig. 2 . The IAS smooth muscle was found to be distinctly sensitive to ANG II because the smooth muscle strips prepared from the distal colon adjacent to the IAS (rectal smooth muscle) elicited either no or a relatively poor contraction. Likewise, in the case of LES, the smooth muscles of opossum displayed maximal contraction with ANG II followed by that in the rat. To the contrary, the rabbit LES showed no significant response to ANG II. The esophageal body of different species examined including opossum produced limited or no contraction with ANG II (data not included).
Effect of selective antagonists of AT 1 Influence of cholinergic and adrenergic antagonists, TTX, and -conotoxin on ANG II-induced rise in the IAS smooth muscle basal tone. ANG II-induced contraction of IAS smooth muscle was not significantly modified by the neurotoxins TTX and -conotoxin, and cholinergic antagonist atropine (1 ϫ 10 Ϫ6 M) (P Ͼ 0.05; Fig. 3 ; n ϭ 5-8). The contraction, however, was partially inhibited by ␣ 1 -adrenoceptor antagonist prazosin (1 ϫ 10 Ϫ5 M) (n ϭ 5-8). We also examined the influence of antagonists of other neurohumoral substances such as histamine (combination of pyrilamine and cimetidine), 5-hydroxytryptamine (methysergide), and prostaglandins (indomethacin) on ANG II-induced contraction of the IAS smooth muscle. None of those neurohumoral antagonists modified significantly the effect of ANG II. In these series of experiments, ANG IIinduced contraction of rat IAS smooth muscle in control was 35.6 Ϯ 3.2 and after the addition of these inhibitors was 29.5 Ϯ 2.8, 32.5 Ϯ 2.6, 33.9 Ϯ 3.9%, respectively (P Ͼ 0.05; n ϭ 5-8). Data suggest that the contractile action of ANG II in the IAS smooth muscle is largely via its direct action on the SMCs. (1 ϫ 10 Ϫ6 M), respectively (P Ͻ 0.05; n ϭ 5-8) (data not shown). Tyrosine kinase inhibitors genistein and tyrphostin caused the maximum attenuation of the ANG II-induced contraction of the IAS smooth muscle.
Effect of ANG II on the SMC isolated from IAS. ANG II caused concentration-dependent contraction of the IAS-SMC. This effect was antagonized significantly by the AT 1 antagonist losartan in a concentration-dependent manner (P Ͻ 0.05; n ϭ 4; Fig. 5 ). The effect of ANG II in the IAS-SMC was not significantly modified by the AT 2 receptor antagonist PD-123319 (data not shown).
Effect of Ca 2ϩ channel blocker, PKC, and tyrosine kinase, Rho kinase and p 44/42 mitogen-activating kinase inhibitors on SMC contraction by ANG II.
Maximal shortening of SMC by ANG II was caused by 1 ϫ 10 Ϫ7 M and was comparable to that induced by bethanechol 1 ϫ 10 Ϫ4 M (Fig. 5) . ; PD-98059). (P Ͻ 0.05; n ϭ 4; Fig. 6 ).
Influence of combined inhibition of different pathways on ANG II-induced contraction of the IAS-SMC.
In a separate series of experiments, we also examined the effect of combined antagonism of Ca 2ϩ channel, PKC, tyrosine kinase, Ca 2ϩ channels, Rho kinase, and MAPK 44/42 . The combination of H-7 and HA-1077 caused significantly more attenuation of ANG II-induced contraction of IAS smooth muscle, compared with their individual use (P Ͻ 0.05; n ϭ 5-8; Fig. 7 ). The combination of Rho kinase and MAPK 44/42 inhibitors also produced significantly higher inhibition of ANG II effects than their individual effect (P Ͻ 0.05; n ϭ 5-8; Fig. 8 ). However, inhibition of tyrosine kinase ANG II in the opossum IAS caused no significant increase, whereas it had a modest effect in the basal tone of the rabbit IAS smooth muscle. Right, effects of ANG II in the LES in different species. Note that the opossum showed the maximal contraction, followed by that in the rat, and contraction was negligible in the rabbit.
pathway by genistein in rat IAS caused significantly greater attenuation of ANG II-induced contraction than that of any other pathway. Data suggest a possible link between tyrosine kinase and other pathways.
Relative distribution of AT 1 and AT 2 receptors in the anorectal versus esophageal smooth muscles of rat. Immunoblots using specific antibodies show the presence of both AT 1 and AT 2 receptors in different tissues examined (Fig. 9) . However, the relative distribution of AT 2 in relation to AT 1 (AT 2 /AT 1 ) was found to be higher in esophageal body (EB) and rectal smooth muscles. The order of calculated relative values of AT 2 /AT 1 was as follows: EB Ͼ rectum Ͼ LES Ͼ IAS (being highest in EB). Western blots are shown in Fig. 9A and densitometric analysis in Fig. 9B . Data suggest that the lack of ANG II response in the nontonic tissues of EB and rectal smooth muscles compared with IAS and LES may not be due to the lack of AT 1 receptors.
DISCUSSION
Present studies for the first time report the actions of ANG II in the IAS smooth muscle. Studies show that rat is an appropriate animal model to investigate the effects and mechanism of action of ANG II and antagonists in the IAS smooth muscle. ANG II causes contraction of rat IAS mostly by its action directly at the smooth muscle. Data suggest that the excitatory effect of ANG II in the IAS involves multiple signal transduction pathways.
Effects of ANG II in the tonic gastrointestinal smooth muscle are not only species specific but also tissue specific. Rat IAS was found to be maximally responsive to the contractile actions of ANG II; rabbit IAS showed a modest contraction, whereas opossum IAS showed no response. Furthermore, the distal co- lonic smooth muscle of rat (rectum) adjacent to the IAS either produces no significant contraction or only a limited contraction by ANG II. Thus rat IAS offers an important model to investigate specific agents (ANG II agonists and antagonists) in the basal tone of the IAS smooth muscle. Agents that cause selective increase or decrease in the basal tone of the IAS smooth muscle are of significance in anorectal incontinence associated with the IAS smooth muscle dysfunction and in the pathophysiology of spastic IAS responsible for severe constipation.
The contractile action of ANG II was determined to be primarily via its action directly at the smooth muscle of the IAS. The excitatory effect of ANG II in the IAS smooth muscle remained intact following pretreatment of the tissues with the neurotoxins TTX and -conotoxin and different neurohumoral antagonists. The only neurohumoral antagonist that caused partial attenuation of ANG II effects was the ␣ 1 adrenoceptorantagonist prazosin. This suggests the involvement of adrenergic nerve terminals activation for a part of the contractile actions of ANG II. Such a partial action of ANG II in the smooth muscle that involves adrenergic nerve terminals has been shown before (4, 13) . Lack of effect of neurotoxins and neurohumoral antagonists on ANG II-induced contraction of IAS smooth muscle combined with contraction of the isolated IAS-SMC following ANG II suggests a majority of ANG II to be via its direct action at the smooth muscle.
Contractile action of ANG II in the IAS smooth muscle is due to the activation of AT 1 receptors. This was evident by the selective antagonism of ANG II effects by the AT 1 receptor antagonist losartan in a concentration-dependent manner. The AT 2 receptor antagonist PD-123319 on the other hand had no significant effect on ANG II-induced contraction of the smooth muscle. This was found to be the case both in the studies with smooth muscle strips and the isolated SMC. Interestingly, the sensitivity of AT 1 receptors to losartan in rat IAS was found to be severalfold more than the opossum LES (7). Whether the AT 1 receptors in the rat IAS smooth muscle being highly sensitive to AT 1 antagonist belong to a specific subclass of AT 1 receptors AT 1A or AT 1B (9, 16) remains to be determined. In addition, the relative density of AT 1 receptors was found to be higher in the rat IAS than the adjoining nonsphincteric smooth muscle of rectum.
It is possible that the net effect of ANG II in a given tissue may not depend entirely on the presence and activation of AT 1 receptors but also on the AT 2 receptors that may otherwise be silent in exerting their independent action. The AT 2 receptors have been shown to suppress the action of the AT 1 receptors (8) . It is of interest that in the present study, the smooth muscle tissues examined not only showed the presence of AT 1 but also AT 2 receptors. Actually, the smooth muscles that respond poorly had a higher ratio of AT 2 /AT 1 receptors, suggesting relatively higher levels of AT 2 receptors in such tissues. The exact significance of the AT 2 receptors and their interaction with the AT 1 in the signal transduction mechanisms by ANG II in these smooth muscles remain to be determined.
ANG II-induced contraction of rat IAS smooth muscle involves multiple pathways, i.e., influx of Ca 2ϩ , and activation of PKC, MAPK 44/42 , and Rho kinase. Antagonism of these pathways by their selective and respective inhibitors caused a partial attenuation of the IAS smooth muscle contraction by ANG II. An increase in the concentration of any of the inhibition caused no further attenuation of ANG II-induced smooth muscle contraction. The combination of the Ca 2ϩ -channel blockade with PKC inhibition and MAPK 44/42 with Rho kinase inhibition by PD-98059 and Y-27632, respectively, caused a small but significant increase in the attenuation of ANG II effects compared with the individual use of the inhibitors. Presently, the exact significance of these findings is not known.
There is an abundance of literature in different systems to suggest that an early upstream activation of tyrosine kinase is involved in ANG II-induced activation of MAPK 44/42 and Rho kinase (2, 14, 21, 22, 25, 28) . Whether such an upstream regulation of tyrosine kinase is involved in the IAS smooth muscle is difficult to ascertain from the present studies. However, in present studies, inhibition of tyrosine kinase produced a greater attenuation of ANG II effects than the individual or combined inhibition of different pathways. Actually, tyrosine kinase inhibition nearly obliterated the effect of ANG II in the IAS smooth muscle. Furthermore, this association between the pathways leading to tyrosine kinase activation and other pathways in the rat IAS smooth muscle is in agreement with the literature cited above but was not found to be the case in the opossum LES (7). In the opossum LES, tyrosine kinase inhibitor genistein had no significant effect on ANG II-induced contraction. Whether there is an upstream regulation of Ca 2ϩ influx, PKC, MAPK 44/42 , and Rho kinase activation by tyrosine kinase, these pathways are completely independent, or there is any cross talk between different pathways for ANG II-induced contraction of the IAS smooth muscle, is not currently known.
The multiplicity of intracellular pathways by agonists like ANG II suggests alternative cellular mechanisms for the maintenance of the tonic smooth muscle contraction (in the basal as well as stimulated state). This may render the tonic smooth muscle adaptable under certain pathophysiological conditions. It is possible that in the acute setting (similar to that presented in studies here), each pathway plays a significant role in the mediation of ANG II effects, and the absence of one may be compensated by other pathway(s).
A lack of reproducible effect of ANG II in the IAS of species other than rat is of significant interest. This may not be simply because of the lack of AT 1 receptors in these species because such receptors were shown to be present there. This, however, may be related to relatively higher levels of AT 2 (reflected in the AT 2 /AT 1 ratios) compared with AT 1 receptors. It is well known that AT 2 receptors, otherwise silent in causing the IAS smooth muscle contraction, may suppress the functional expression of AT 1 receptors. Further studies are needed to resolve this issue. Another explanation for the species differences in the actions of ANG II may be the differences in signal transduction machinery linked to AT 1 receptor of IAS SMCs of different species.
In summary, we conclude that rat IAS provides an excellent model to pursue the investigation of ANG II for the following aspects: characterization of ANG II receptor types, role of ANG II in the pathophysiology and therapeutic potentials of anorectal motility disorders, signal transduction cascade for the IAS smooth muscle contraction; and determination of the significance of AT 2 receptors in gastrointestinal smooth muscle.
